Top Stories

Curated By Isabella Tang

By Isabella Tang 2026-01-16

Trip.com Shares Plunge Over 20% Amid Antitrust Probe in China

Trip.com, a leading online travel agency, faces a significant decline in stock value as Chinese authorities launch an antitrust investigation into the company. The probe raises concerns about regulatory scrutiny in China's rapidly evolving tech landscape.

By Isabella Tang 2026-01-15

Tseung Kwan O Emerges as Dominant Hub in Hong Kong's Data Center Market

The Hong Kong Data Center Market Investment Analysis Report projects Tseung Kwan O as the central hub for data center development, accounting for nearly 41% of existing white space. This growth is set to reshape the digital landscape and attract significant investments in the coming years.

By Isabella Tang 2026-01-15

OnePlus Founder Carl Pei Wanted by Taiwanese Authorities

Carl Pei, the founder of OnePlus, is reportedly wanted by Taiwanese authorities for alleged financial misconduct. This development raises questions about the future of Pei's ventures and the tech industry's regulatory landscape in Taiwan.

By Isabella Tang 2026-01-15

英硅智能 IPO 后热度不减 再签 8.88 亿美元大单

英硅智能在成功上市后,继续保持强劲的市场表现,近期签署了一份价值 8.88 亿美元的合同,显示出其在智能科技领域的竞争力。此举不仅巩固了其市场地位,也为未来发展奠定了坚实基础。

By Isabella Tang 2026-01-15

Asian Markets Mixed as Tokyo Rises on Election Speculation

Asian markets showed a mixed performance today, with Tokyo's Nikkei index gaining ground amid speculation surrounding upcoming elections. Investors remain cautious as they navigate through geopolitical tensions and economic uncertainties.

By Isabella Tang 2026-01-14

Taiwan Issues Arrest Warrant for OnePlus CEO Pete Lau

Taiwan has issued an arrest warrant for Pete Lau, the CEO of OnePlus, amidst allegations related to business practices. The warrant raises significant questions about international business operations and legal jurisdictions.

By Isabella Tang 2026-01-14

WHO's New Pandemic Approach: Expediency Over Evidence?

The World Health Organization's recent strategies in managing global health crises have sparked debate over the balance between speed and scientific rigor. Critics argue that the shift towards expediency could undermine the integrity of public health responses.